Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |